Delivery Order SPE2DB22D3019-SPE2DB25FK3YP
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,916.05 to supply 4562690670 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania headquarters, with completion by November 3, 2023. No set-aside designation was applied to this order, which was awarded against an indefinite-delivery contract held by Amerisourcebergen with the Department of...
- The Defense Logistics Agency awarded a $19,160.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561557895 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support its medical product procurement and distribution activities. No subcontractors or set aside designations were identified. This order is likely part of DLA's...
- This is a $4,212.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a vaccine product, with a completion date of June 17, 2025. The contract is not set-aside and appears to be part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical. This IDC enables...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,212.40, is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has an ultimate completion date of June 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is an established federal contractor, holding a $999,999,999.00...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,916.05 to supply 4562704154 HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 6, 2023. As a prime contractor and subsidiary of Amerisourcebergen Corporation, Amerisourcebergen Drug Corp routinely provides pharmaceuticals and medical supplies...
- The Defense Logistics Agency awarded a $4,215.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania corporate office. The order has a period of performance from September 20, 2023 through September 21, 2023 to supply hepatitis B vaccines in pre-filled syringes to support the Department of Defense's immunization programs. No major subcontractors or set aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $6,140.37. The order is for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a hepatitis B vaccine. This order does not have a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen...
- This is a $3,075.81 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes, which are used for hepatitis B vaccinations. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. The IDC serves...
- This is a $158,368.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities and programs. The company also holds an...
- This delivery order for HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $1,577.28 firm fixed price award has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations mentioned. This order is issued under an indefinite delivery contract (IDC) valued at up...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK3YPDelivery Order
4568853374 ! HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML
Posted 7/21/25
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/21/25 |